Milo Biotechnology Receives $250,000 New Funding Round

  • Feed Type
  • Date
    2/17/2012
  • Company Name
    Milo Biotechnology
  • Mailing Address
    Undisclosed Cleveland, OH 44101
  • Company Description
    Milo Biotechnology is a Cleveland-based company dedicated to improving the lives of patients with neuromuscular diseases. Milo’s early clinical stage follistatin program, exclusively licensed from Nationwide Children’s Hospital, is designed to increase muscle size and strength.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $250,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Jumpstart

By posting a comment, you agree to our terms and conditions.